RR

Rati Rushabh Kothari

Active Director Designated Partner DIN 11535318
DIN 11535318 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rati Rushabh Kothari

Data last updated:

Rati Rushabh Kothari is a Designated Partner at Banas Cancer And Research Institute Llp (since 2026).

DIN 11535318
Primary Designation Designated Partner
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Banas Cancer And Research Institute Llp
Premium access

Shareholding and investment profile for Rati Rushabh Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rati Rushabh Kothari

Rati Rushabh Kothari currently holds 1 directorship: Banas Cancer And Research Institute Llp (Designated Partner, since 09 Feb 2026).

Rati Rushabh Kothari was first appointed on 09 Feb 2026 as Designated Partner at Banas Cancer And Research Institute Llp.

The current boards of Rati Rushabh Kothari's companies include Geeta Itesh Khatwani (Banas Cancer And Research Institute Llp), Maniben Ghemarbhai Chaudhary (Banas Cancer And Research Institute Llp), Mukeshkumar Prahladji Chaudhary (Banas Cancer And Research Institute Llp), Ramilaben Ghemarbhai Chaudhari (Banas Cancer And Research Institute Llp), Shreya Gaurang Modi (Banas Cancer And Research Institute Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available